栄研化学の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/01/30 | 1,781 | 1,792 | 1,729 | 1,739 | -39 | -2.2% | 124,300 |
| 2024/01/29 | 1,768 | 1,784 | 1,765 | 1,778 | +10 | +0.6% | 113,000 |
| 2024/01/26 | 1,760 | 1,788 | 1,757 | 1,768 | +13 | +0.7% | 146,300 |
| 2024/01/25 | 1,741 | 1,757 | 1,736 | 1,755 | +18 | +1% | 117,300 |
| 2024/01/24 | 1,740 | 1,747 | 1,731 | 1,737 | -23 | -1.3% | 89,900 |
| 2024/01/23 | 1,770 | 1,787 | 1,756 | 1,760 | -13 | -0.7% | 98,400 |
| 2024/01/22 | 1,758 | 1,779 | 1,758 | 1,773 | +15 | +0.9% | 78,000 |
| 2024/01/19 | 1,760 | 1,769 | 1,736 | 1,758 | +6 | +0.3% | 139,800 |
| 2024/01/18 | 1,734 | 1,759 | 1,729 | 1,752 | +15 | +0.9% | 93,200 |
| 2024/01/17 | 1,820 | 1,838 | 1,735 | 1,737 | -80 | -4.4% | 289,100 |
| 2024/01/16 | 1,835 | 1,849 | 1,813 | 1,817 | -3 | -0.2% | 280,300 |
| 2024/01/15 | 1,802 | 1,823 | 1,790 | 1,820 | +32 | +1.8% | 183,300 |
| 2024/01/12 | 1,738 | 1,798 | 1,715 | 1,788 | +59 | +3.4% | 270,800 |
| 2024/01/11 | 1,735 | 1,742 | 1,706 | 1,729 | +4 | +0.2% | 103,500 |
| 2024/01/10 | 1,705 | 1,741 | 1,700 | 1,725 | +25 | +1.5% | 145,000 |
| 2024/01/09 | 1,704 | 1,720 | 1,699 | 1,700 | -10 | -0.6% | 123,400 |
| 2024/01/05 | 1,713 | 1,720 | 1,694 | 1,710 | +3 | +0.2% | 148,700 |
| 2024/01/04 | 1,701 | 1,709 | 1,678 | 1,707 | -2 | -0.1% | 69,700 |
| 2023/12/29 | 1,718 | 1,726 | 1,697 | 1,709 | -9 | -0.5% | 103,300 |
| 2023/12/28 | 1,696 | 1,718 | 1,693 | 1,718 | +11 | +0.6% | 198,300 |
| 2023/12/27 | 1,700 | 1,709 | 1,695 | 1,707 | +4 | +0.2% | 80,900 |
| 2023/12/26 | 1,700 | 1,707 | 1,691 | 1,703 | +5 | +0.3% | 97,400 |
| 2023/12/25 | 1,722 | 1,723 | 1,692 | 1,698 | -21 | -1.2% | 67,900 |
| 2023/12/22 | 1,701 | 1,721 | 1,701 | 1,719 | +8 | +0.5% | 72,500 |
| 2023/12/21 | 1,706 | 1,718 | 1,701 | 1,711 | -2 | -0.1% | 82,300 |
| 2023/12/20 | 1,718 | 1,728 | 1,705 | 1,713 | +2 | +0.1% | 95,900 |
| 2023/12/19 | 1,707 | 1,718 | 1,693 | 1,711 | -2 | -0.1% | 127,700 |
| 2023/12/18 | 1,689 | 1,722 | 1,681 | 1,713 | +8 | +0.5% | 108,200 |
| 2023/12/15 | 1,734 | 1,735 | 1,698 | 1,705 | -22 | -1.3% | 160,300 |
| 2023/12/14 | 1,729 | 1,736 | 1,703 | 1,727 | -1 | -0.1% | 137,700 |
| 2023/12/13 | 1,724 | 1,740 | 1,707 | 1,728 | +21 | +1.2% | 168,200 |
| 2023/12/12 | 1,730 | 1,733 | 1,691 | 1,707 | -18 | -1% | 169,600 |
| 2023/12/11 | 1,748 | 1,748 | 1,714 | 1,725 | -3 | -0.2% | 135,500 |
| 2023/12/08 | 1,764 | 1,764 | 1,714 | 1,728 | -23 | -1.3% | 175,600 |
| 2023/12/07 | 1,749 | 1,768 | 1,743 | 1,751 | -13 | -0.7% | 119,600 |
| 2023/12/06 | 1,718 | 1,764 | 1,713 | 1,764 | +73 | +4.3% | 251,000 |
| 2023/12/05 | 1,694 | 1,704 | 1,683 | 1,691 | -10 | -0.6% | 117,800 |
| 2023/12/04 | 1,675 | 1,704 | 1,661 | 1,701 | +6 | +0.4% | 147,000 |
| 2023/12/01 | 1,680 | 1,714 | 1,680 | 1,695 | +48 | +2.9% | 283,600 |
| 2023/11/30 | 1,640 | 1,650 | 1,632 | 1,647 | -8 | -0.5% | 127,900 |
| 2023/11/29 | 1,638 | 1,664 | 1,638 | 1,655 | +11 | +0.7% | 131,500 |
| 2023/11/28 | 1,669 | 1,669 | 1,612 | 1,644 | -27 | -1.6% | 259,000 |
| 2023/11/27 | 1,665 | 1,696 | 1,665 | 1,671 | +6 | +0.4% | 195,900 |
| 2023/11/24 | 1,652 | 1,673 | 1,643 | 1,665 | +27 | +1.6% | 238,900 |
| 2023/11/22 | 1,623 | 1,650 | 1,618 | 1,638 | +28 | +1.7% | 297,800 |
| 2023/11/21 | 1,573 | 1,613 | 1,569 | 1,610 | +26 | +1.6% | 304,400 |
| 2023/11/20 | 1,559 | 1,591 | 1,556 | 1,584 | +29 | +1.9% | 275,100 |
| 2023/11/17 | 1,526 | 1,556 | 1,526 | 1,555 | +26 | +1.7% | 117,900 |
| 2023/11/16 | 1,560 | 1,564 | 1,528 | 1,529 | -26 | -1.7% | 118,500 |
| 2023/11/15 | 1,556 | 1,573 | 1,550 | 1,555 | ±0 | ±0% | 169,700 |
201～
250
件表示中 / 6839件
類似銘柄と比較する
現在ご覧いただいている「栄研化」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 栄研化 | 210,100円 | +0.4% | -8.4% | 2.52% | 27.77倍 | 1.58倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| 杏林製薬 | 149,100円 | +3.2% | +4.5% | 3.49% | 17.13倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| ＪＣＲファーマ | 69,600円 | -3.7% | -36.7% | 2.87% | 22.92倍 | 1.50倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| サンバイオ | 96,700円 | - | - | 0.00% | - | 48.69倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| あすかＨＤ | 203,600円 | +0.3% | +2.7% | 2.46% | 11.55倍 | 0.90倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。２１年春にあすか製薬が持株会社化 |
市場注目の銘柄
チャート関連のコラム
